Home › Stocks › LAB › All Fund Holders
LAB — STANDARD BIOTOOLS INC · All Fund Holders
Funds holding (latest): 39 · Reported value held: $179.22M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Casdin Capital history | Q2 2026 | 88.78M | $73.04M | 3.66% | Hold |
| Viking Global Investors history | Q2 2026 | 58.65M | $48.25M | 0.14% | Hold |
| Vanguard Group history | Q4 2025 | 17.30M | $22.14M | 0.00% | Hold |
| BlackRock Inc history | Q2 2026 | 8.25M | $6.79M | 0.00% | Reduce |
| ARK Invest history | Q4 2025 | 3.07M | $3.93M | 0.03% | Add |
| Royce & Associates history | Q2 2026 | 4.53M | $3.72M | 0.03% | Add |
| Geode Capital Management history | Q2 2026 | 3.90M | $3.21M | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 3.51M | $2.89M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 2.83M | $2.33M | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 2.82M | $2.32M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 2.38M | $1.96M | 0.00% | Add |
| Arrowstreet Capital history | Q2 2026 | 1.99M | $1.64M | 0.00% | New |
| Charles Schwab Investment Management history | Q2 2026 | 1.76M | $1.45M | 0.00% | Reduce |
| AQR Capital Management history | Q2 2026 | 1.36M | $1.12M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 992.06K | $816.17K | 0.00% | New |
| Northern Trust Corp history | Q2 2026 | 791.53K | $651.19K | 0.00% | Reduce |
| Point72 Asset Management history | Q2 2026 | 707.99K | $582.46K | 0.00% | Add |
| Two Sigma Investments history | Q4 2024 | 286.94K | $502.15K | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 425.98K | $350.58K | 0.00% | Add |
| Deutsche Bank AG history | Q1 2026 | 285.77K | $262.91K | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 244.08K | $200.64K | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 221.91K | $182.56K | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 216.42K | $178.05K | 0.00% | Reduce |
| Legal & General Investment Management America history | Q1 2026 | 159.54K | $146.66K | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 131.61K | $121.38K | 0.00% | Hold |
| Marshall Wace history | Q3 2024 | 58.15K | $112.22K | 0.00% | Reduce |
| Manulife Financial history | Q1 2026 | 81.55K | $74.97K | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 90.28K | $74.27K | 0.00% | Reduce |
| Prudential Financial history | Q2 2026 | 60.32K | $49.63K | 0.00% | Add |
| Corvex Management history | Q1 2026 | 44.34K | $40.76K | 0.00% | Hold |
| Balyasny Asset Management history | Q2 2026 | 38.53K | $31.70K | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 23.40K | $19.25K | 0.00% | Reduce |
| Amundi US history | Q1 2025 | 14.50K | $15.51K | 0.00% | Hold |
| Principal Global Investors history | Q1 2026 | 13.89K | $12.77K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 10.10K | $8.31K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 7.00K | $5.23K | 0.00% | New |
| Fidelity Management & Research (FMR) history | Q2 2026 | 3.15K | $2.59K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q1 2026 | 202.47K | $187 | 0.00% | Add |
| PNC Financial Services history | Q2 2026 | 128 | $105 | 0.00% | Hold |